Rationale for Fixed Dosing of Pertuzumab in Cancer Patients Based on Population Pharmacokinetic Analysis

Pharmaceutical Research ◽

10.1007/s11095-006-0205-x ◽

2006 ◽

Vol 23 (6) ◽

pp. 1275-1284 ◽

Author(s):

Chee M. Ng ◽

Bert L. Lum ◽

Veronica Gimenez ◽

Steve Kelsey ◽

David Allison

Keyword(s):

Cancer Patients ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic

Download Full-text

Population Pharmacokinetic Analysis of Cisplatin and Its Metabolites in Cancer Patients: Possible Misinterpretation of Covariates for Pharmacokinetic Parameters Calculated from the Concentrations of Unchanged Cisplatin, Ultrafiltered Platinum and Total Platinum

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hye040 ◽

2001 ◽

Vol 31 (5) ◽

pp. 179-184 ◽

Author(s):

K. Hanada

Keyword(s):

Cancer Patients ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Pharmacokinetic Parameters ◽

Population Pharmacokinetic ◽

Total Platinum ◽

Unchanged Cisplatin

Download Full-text

Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity

Current Topics in Medicinal Chemistry ◽

10.2174/156802612803531414 ◽

2012 ◽

Vol 12 (15) ◽

pp. 1713-1719 ◽

Author(s):

Christian Woloch ◽

Antonello Di Paolo ◽

Hafedh Marouani ◽

Guido Bocci ◽

Joseph Ciccolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Intestinal Toxicity ◽

Colorectal Cancer Patients

Download Full-text

Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation

British Journal of Clinical Pharmacology ◽

10.1111/bcp.12778 ◽

2015 ◽

Vol 81 (1) ◽

pp. 148-160 ◽

Author(s):

Kelong Han ◽

Thomas Peyret ◽

Angelica Quartino ◽

Nathalie H. Gosselin ◽

Sridharan Gururangan ◽

...

Keyword(s):

Cancer Patients ◽

External Validation ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Paediatric Cancer ◽

Dosing Strategy

Download Full-text

Pooled Population Pharmacokinetic Analysis of Phase I, II and III Studies of Linifanib in Cancer Patients

Clinical Pharmacokinetics ◽

10.1007/s40262-013-0121-2 ◽

2013 ◽

Vol 53 (4) ◽

pp. 347-359 ◽

Author(s):

Ahmed Hamed Salem ◽

Denise Koenig ◽

Dawn Carlson

Keyword(s):

Phase I ◽

Cancer Patients ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic

Download Full-text

Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors

Investigational New Drugs ◽

10.1007/s10637-019-00744-0 ◽

2019 ◽

Vol 37 (6) ◽

pp. 1218-1230

Author(s):

Fei Tang ◽

Eleftheria Tsakalozou ◽

Susanne M. Arnold ◽

Chee M. Ng ◽

Markos Leggas

Keyword(s):

Cancer Patients ◽

Solid Tumors ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Camptothecin Analogue

Download Full-text

Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-005-0036-1 ◽

2005 ◽

Vol 57 (4) ◽

pp. 401-411 ◽

Author(s):

Jane E Latz ◽

Ajai Chaudhary ◽

Atalanta Ghosh ◽

Robert D Johnson

Keyword(s):

Clinical Trials ◽

Cancer Patients ◽

Phase Ii ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Phase Ii Clinical Trials

Download Full-text

552 POSTER Integrated population pharmacokinetic analysis of temsirolimus in cancer patients following weekly IV treatments

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)70557-2 ◽

2006 ◽

Vol 4 (12) ◽

pp. 167-168 ◽

Author(s):

J.P. Boni ◽

S. Zhou ◽

J. Burns ◽

K. Smith ◽

S. Liao

Keyword(s):

Cancer Patients ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic

Download Full-text

Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-1376 ◽

2007 ◽

Vol 13 (22) ◽

pp. 6703-6711 ◽

Author(s):

Paula Schaiquevich ◽

John C. Panetta ◽

Lisa C. Iacono ◽

Burgess B. Freeman ◽

Victor M. Santana ◽

...

Keyword(s):

Cancer Patients ◽

Pediatric Cancer ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Pediatric Cancer Patients

Download Full-text

Population Pharmacokinetic Analysis of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) in Adult and Pediatric Patients with Severe Hemophilia B

10.1055/s-0039-1680223 ◽

2019 ◽

Author(s):

Y. Zhang ◽

W. McKeand ◽

T. Yuraszeck ◽

W. Seifert ◽

A. Feussner ◽

...

Keyword(s):

Fusion Protein ◽

Pediatric Patients ◽

Coagulation Factor ◽

Population Pharmacokinetic Analysis ◽

Factor Ix ◽

Hemophilia B ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Severe Hemophilia ◽

Coagulation Factor Ix

Download Full-text

Population pharmacokinetic analysis of the microemulsion formulation of cyclosporin A (NeoralR) in renal transplant patients

Therapy ◽

10.1586/14750708.3.2.259 ◽

2006 ◽

Vol 3 (2) ◽

pp. 259-264

Author(s):

Dawei Xuan ◽

Charles H Nightingale ◽

David Hull ◽

David P Nicolau

Keyword(s):

Renal Transplant ◽

Cyclosporin A ◽

Population Pharmacokinetic Analysis ◽

Pharmacokinetic Analysis ◽

Population Pharmacokinetic ◽

Microemulsion Formulation ◽

Transplant Patients ◽

Renal Transplant Patients

Download Full-text